Founded by the visionary Shri Indravadan Ambalal Modi in 1952, Cadila Pharmaceuticals Ltd. stands today as one of India's largest privately held pharmaceutical companies. Headquartered in Ahmedabad, Gujarat, the company has been a cornerstone of Indian healthcare innovation for over seven decades - developing, manufacturing, and distributing quality medicines in more than 100 countries worldwide.
Shri I.A. Modi, fondly known as the "Medicine Man of India," laid the foundation of Cadila Laboratories on March 13, 1952. One of its earliest products, Livirubra, a vitamin supplement in liquid form, marked the beginning of Cadila's enduring commitment to accessible healthcare. In 1967, the establishment of its first factory in Ghodasar, Ahmedabad, heralded a period of rapid expansion and industrial growth. Beyond his entrepreneurial pursuits, Shri Modi played a pivotal role in shaping the Indian pharmaceutical landscape - championing the Indian Patents Act of 1970 and contributed to the formulation of the 1986 Drug Policy of India. His tireless efforts ensured that life saving medicines reached even the most marginalized sections of society.
Today, Cadila Pharmaceuticals continues to honor its founder's legacy through innovation, inclusivity, and people-centric progress. The company has emerged as a frontrunner in breakthrough healthcare solutions, such as ThRabis®, a three-dose rabies vaccine that won the ET Pharma World Award 2023 for "Innovation Pharma of the Year." In 2024, Cadila achieved another global milestone by launching the world's first aqueous formulation of cholecalciferol (Vitamin D injection), setting a new benchmark in the treatment of Vitamin D deficiency.
While its scientific achievements are widely recognized, Cadila's evolution as a future-ready workplace is equally remarkable. The company has embraced a comprehensive transformation in its people practices, positioning itself as a modern, human-centered organization that seamlessly blends technology with empathy.
At the heart of this transformation lies Cadila's digital HR ecosystem - a robust platform that streamlines every stage of the employee journey. From paperless onboarding and integrated employee services to performance management, personalized learning, and real-time communication tools, the organization has reimagined how employees engage with their workplace. These initiatives not only enhance operational efficiency but also ensure a consistent, transparent, and empowering experience for every member of the Cadila family.
Accessibility and flexibility also play a central role in this evolution. Cadila's digital systems are designed to support employees across diverse geographies and roles, whether working from the office, remotely, or on the move. This focus on inclusivity ensures that every employee has equal access to information, development opportunities, and organizational support, reinforcing a sense of belonging and empowerment.
Trust, openness, and teamwork form the foundation of Cadila’s approach to leadership and employee engagement. The company has created a space where individuals feel safe to voice ideas, share feedback, and contribute meaningfully to collective goals. This openness has strengthened innovation and engagement, enabling teams to work cohesively toward the company's broader mission, delivering affordable and quality healthcare for all.
Under its forward-looking leadership, Cadila Pharmaceuticals exemplifies how a legacy enterprise can evolve without losing its human touch. The company continues to nurture a workplace that is agile, inclusive, and deeply empathetic, one where people are not just employees but valued contributors to a shared vision.
